Kyodo University To Provide Pharmaceutical Companies iPS Cells
This article was originally published in PharmAsia News
Executive Summary
Effective July 7, Kyodo University will begin providing human and mouse induced pluripotent stem cells to private enterprises such as pharmaceutical companies. For a fee, the university will provide iPS cells made from skin cells induced by three or four genes. The iPS research center at Kyoto University is also available to provide cell culture guidance to companies. The duration of service will be for one year and intellectual property issues will be dealt with between the center and the companies. It is the first time the school will provide such service to the private sector. Kyoto University provided mouse iPS cells to Riken Bioresource Center, a research facility, in March. (Click here for more - Japanese language